Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Sys…
この記事を読む
記事一覧 32ページ
この記事を読む
中枢型肺腺癌では骨転移が多く予後不良
New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter coh…
この記事を読む
細胞診スメアでもPD-L1高発現は診断可能
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced …
この記事を読む
オシメルチニブの肺毒性、日本人は特に多い
Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian…
この記事を読む
いわゆるオリゴメタに対する局所治療～傾向スコア研究
Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 pat…
この記事を読む
オリゴメタの同定にはPET/CTがよい
Detection of oligoprogressive disease in oncogene-addicted non-small cell lung cancer using PET/CT versus CT in patients…
この記事を読む
ゲノム医療の恩恵を受けられるのはまだまだ少ない
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology. Marquart J et al. JAMA …
この記事を読む
TP53変異の共存はALK陽性肺癌の予後に影響する
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Kron A et al …
この記事を読む
術後肺癌の予後スコア化、TNM＋他因子でより層別化可能？
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The developme…
この記事を読む
T790M変異の喪失はオシメルチニブ耐性までの時間と関連
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acqui…